Tacrine does not alter the potency of succinylcholine in the rat

[1]  F. Donati,et al.  The Effects of Chronic Tacrine Therapy on d-Tubocurarine Blockade in the Soleus and Tibialis Muscles of the Rat , 1997, Anesthesia and analgesia.

[2]  Gastone G. Celesia,et al.  A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease , 1994 .

[3]  P. Watkins,et al.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. , 1994, JAMA.

[4]  P. Solomon,et al.  A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. , 1994, JAMA.

[5]  G. Baker,et al.  Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium. , 1994, British journal of anaesthesia.

[6]  Martin R. Farlow,et al.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. , 1992, JAMA.

[7]  R. S. Jaffe,et al.  Up‐and-down Regulation of Skeletal Muscle Acetylcholine Receptors Effects on Neuromuscular Blockers , 1992, Anesthesiology.

[8]  D. Mash,et al.  Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. , 1989, The Journal of pharmacology and experimental therapeutics.

[9]  D. Silverman,et al.  OPTIMIZING POSTOPERATIVE ANALGESIA WITH A RAPIDLY ACTING EPIDURAL NARCOTICRESULTS OF A PROSPECTIVE RANDOMIZED DOUBLE BLINDED STUDY , 1988 .

[10]  F. Donati,et al.  Dose—response Curves for Succinylcholine: Single Versus Cumulative Techniques , 1987, Anesthesiology.

[11]  L. Fitten,et al.  Long-term oral administration of memory-enhancing doses of tacrine in mice: a study of potential toxicity and side effects. , 1987, Journal of gerontology.

[12]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.

[13]  E. Zaimis,et al.  Depolarising Neuromuscular Blocking Drugs , 1976 .

[14]  C. Chang,et al.  Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragm , 1973, The Journal of physiology.

[15]  A. Comeau,et al.  Pseudocholinesterases of mammalian plasma: physicochemical properties and organophosphate inhibition in eleven species. , 1973, Toxicology and applied pharmacology.

[16]  J. H. Wills,et al.  The Measurement and Significance Of Changes In The Cholinesterase Activities Of Erythrocytes and Plasma In Man and Animals , 1972 .

[17]  A. W. Rogers,et al.  DETERMINATION OF THE NUMBER, DISTRIBUTION, AND SOME IN SITU PROPERTIES OF CHOLINESTERASE MOLECULES IN THE MOTOR END PLATE, USING LABELED INHIBITOR METHODS , 1967 .

[18]  D. Macdonald.  Dual block following tacrine and suxamethonium. , 1967, British journal of anaesthesia.

[19]  R. Katz,et al.  The action of tacrine on neuromuscular transmission: a comparison with hexafluorenium. , 1966, British journal of anaesthesia.